Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed Reports Full Year 2023 Financial Results 2024-03-28 22:10
GenFleet and BeiGene Enter into Trial Collaboration for a Potentially First-in-class Combination Therapy to Initiate Phase Ib/II Study of GFH009 (CDK9 inhibitor) and BRUKINSA® (zanubrutinib) Treating Diffuse Large B Cell Lymphoma 2024-03-28 19:00
Tigermed Reports Full Year 2023 Results 2024-03-28 18:31
Sirnaomics Announces 2023 Annual Results 2024-03-28 17:09
CARsgen Announced 2023 Annual Results 2024-03-27 20:50
Sanyou Bio: Sanyou's Intelligence-Enabled Innovative Biologics R&D Platform Leads in the New Era of Biological Drug Development 2024-03-27 20:00
YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean 2024-03-27 20:00
Recbio And Rongsheng Biotech Signed a Strategic Cooperation Agreement On The New Adjuvant Vaccine Project 2024-03-27 11:24
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy 2024-03-27 08:00
Bridge Biotherapeutics Announces a Research Collaboration with the University of Colorado School of Medicine to Explore Potential of BBT-877 for Immuno-Oncology 2024-03-27 06:00
World First Use of Lightpoint's SENSEI® Drop-In Gamma Probe in Bladder Cancer Surgery Performed in Spain 2024-03-27 05:59
WuXi Biologics Reports Solid 2023 Annual Results 2024-03-26 21:53
ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis 2024-03-26 21:00
Lunit SCOPE IO Reveals Promising Results in Neoadjuvant Immunotherapy Study for Head and Neck Cancer Patients 2024-03-26 21:00
TiumBio Submits CTA for Phase 1b Clinical Trial of TU7710, a Long-acting Recombinant Activated Factor VII, in Hemophilia A or B Patients 2024-03-26 20:00
Alphamab Oncology Announces the First Patient Dosed in Australia in the Clinical Study of Subcutaneous Formulation JSKN033 2024-03-26 09:57
Scivita Medical Expands Collaboration with Boston Scientific 2024-03-26 09:30
BioDuro-Sundia's Partner, DigmBio Announced IND Clearance from Korea MFDS for its Selective PARP1 Inhibitor DM5167 2024-03-26 08:30
Full-Life Technologies Achieves Regulatory Milestone with Nuclear Permit, Advancing Radioisotope Facility Construction 2024-03-26 08:00
GC Genome to Present New Data at AACR 2024 2024-03-25 21:00
1 8.5 9.5 10.5 11.5 12.5 415